See: Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development BPL-003 is a synthetic and patent-protected benzoate salt formulation of 5-MeO-DMT (aka mebufotenin ...

Among various recycling approaches, catalytic methanolysis to dimethyl terephthalate (DMT) shows particular promise due to its direct integration into PET synthesis cycles. While supercritical ...

Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a Phase 2a study of Beckley’s novel formulation of 5-MeO-DMT in Treatment ...